At Hitachi Vantara, our mission is to help customers extract all the value of their data through our DataOps methodology, which helps them achieve tangible outcomes that positively drive business and society forward. One field where we’re making advances – which also strikes a personal chord with me, given my background as a biomedical engineer – is in the field of cardiovascular medicine. Specifically, I’m referring to our work with the American Heart Association (AHA).
The AHA is devoted to saving people from heart diseases and stroke—two of the leading causes of death in the world. The AHA established the Institute for Precision Cardiovascular Medicine to advance the science of precision cardiovascular and brain health. Precision medicine considers an individual’s genetics, environment and lifestyle in tailoring treatments and looks for patterns across diverse datasets to identify disease triggers or to explain lack of disease.
In order for data scientists in the medical research field to engage in discovery, it’s important to understand first that medical research data is far-reaching and plentiful. There are thousands of people, institutions and businesses that research, analyze and draw conclusions based on the data they curate. Much of the research and data is high-quality, valuable and has a high level of integrity. However, like many other industries, there is no single repository where the data is housed and easily searchable. As a result, researchers spend significant time probing various datasets for specific information and often duplicate the efforts of other researchers. Cumulatively, this ends in substantial loss of time, money and effort.
The Institute wanted to solve this problem and launched a strategic initiative called the Precision Medicine Platform, a cloud-based technology solution that enables the global medical research community to accelerate breakthroughs in cardiovascular and brain diseases. With the help of Hitachi Vantara, AHA was able to migrate its workloads to the cloud securely and gain a holistic digital transformation. Our solutions are proven to move workloads to the cloud 60% faster and achieve deployments that are 100% consistent.
“Our mission is to be a relentless force for longer, healthier lives. Disruption in data analysis is now changing the way we and others solve for longer, healthier lives. The vision of our CEO was to create the Precision Medicine Platform, which was ahead of its time in providing a state-of-the-art, ready-to-run, data science environment. Watching the Platform enable game-changing data analyses has changed the way we think about the art of the possible. This is really exciting,” said Dr. Jen Hall, chief of the Institute for Precision Cardiovascular Medicine, American Heart Association.
The AHA Precision Medicine Platform enables researchers to quickly determine which datasets they need and how they were harmonized. It also offers secure workspaces equipped with artificial intelligence and machine learning tools for data analysis. These workspaces enable researchers to work collaboratively and securely to accelerate discovery. The flexibility and agility the Platform provides to the research community can enable scientists to amalgamate research, identify trends and provide real-time solutions based on empirical data.
“Hitachi Vantara is the trusted partner of choice to help us continue making positive impacts to society. We continue to work with them to develop the Platform and provide ongoing operations support in managing the environment. The Platform fundamentally changes the way the medical research community collaborates, and through our investments in technology we can accelerate discoveries for both heart disease and stroke patients,” added Hall.
#DataOps #healthcare #AmericanHeartAssociation #PoweringGood